Your browser does not support the NLM PubReader view.
Go to this page to see a list of supported browsers
or return to the
regular view.

Page 0 of 0

NCBI Bookshelf

Home Browse All Titles Share on Facebook Share on Twitter

Table of Content

National Institute for Health and Care Excellence: Guidelines Title Information Table of Contents Page

Settings

Switch to classic view PDF (2.7M)Print View

Help

Help Send us feedback About PubReader

✘

Drug Allergy

Guideline Development Group members
NCGC technical team members
Co-optees
Acknowledgements
1. Introduction
2. Development of the guideline
3. Methods
4. Algorithm
5. Guideline summary
6. Assessment
7. Measuring serum tryptase after suspected anaphylaxis
8. Measuring serum specific immunoglobulin E (IgE)
9. Documenting and sharing information with other healthcare professionals
10. Providing information and support to patients
11. Non-specialist management
12. Referral to specialist drug allergy services
13. Acronyms and glossaries of terms used in the guideline
14. References
Appendix A. Scope
Appendix B. Declarations of interest
Appendix C. Clinical review protocols
Appendix D. Economic review protocol
Appendix E. Clinical article selection
Appendix F. Economic article selection
Appendix G. Literature search strategies
Appendix H. Clinical evidence tables
Appendix I. Economic evidence tables
Appendix J. Forest plots
Appendix K. Excluded clinical studies
Appendix L. Excluded economic studies
Appendix M. Research recommendations
Appendices References